Ekaterina L. Andrianova

OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis

Lioubov G. Korotchkina, Denis Kazyulkin, Pavel G. Komarov et al. · Leukemia · 2020 · 64 citations · Full text

Medicine, Oncology, Pharmacology +12

Antioxidant and neuroprotective properties of N-arachidonoyldopamine

Anatoly A. Lizhin, Ekaterina L. Andrianova, N. M. Gretskaya · Neuroscience Letters · 2007 · 52 citations

Life Sciences, Neurobiology, Neuroscience +12

A deimmunized and pharmacologically optimized Toll-like receptor 5 agonist for therapeutic applications

Vadim Mett, Oleg V. Kurnasov, Ivan A. Bespalov et al. · Communications Biology · 2021 · 33 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Unsupervised learning of aging principles from longitudinal data

Konstantin Avchaciov, Marina P. Antoch, Ekaterina L. Andrianova et al. · Nature Communications · 2022 · 28 citations · Full text

Education, Biostatistics, Physiology +17

Development of infrastructure for a systemic multidisciplinary approach to study aging in retired sled dogs

Daria Fleyshman, Joseph J. Wakshlag, Heather J. Huson et al. · Aging · 2021 · 15 citations · Full text

Education, Animal Sciences, Veterinary Physiology +17